HOME >> BIOLOGY >> NEWS
Joslin President awarded medal from international diabetes organization

BOSTON - C. Ronald Kahn, M.D., President and Director of Joslin Diabetes Center, has been awarded the 2004 Claude Bernard Medal by the European Association for the Study of Diabetes (EASD) at the organization's 40th Annual Meeting in Munich, Germany. This prestigious award recognizes innovative leadership and superior contributions in the field of diabetes research and is the highest scientific honor awarded by the EASD. Dr. Kahn also is the Mary K. Iacocca Professor of Medicine at Harvard Medical School.

As part of the honor, Dr. Kahn presented the distinguished Claude Bernard Lecture, considered to be the highlight of the weeklong EASD annual meeting, which was held Sept. 5-9. Dr. Kahn discussed how communication between the brain and tissues of the body relates to the pathogenesis of diabetes. Dr. Ele Ferrannini, the president of the EASD, presented Dr. Kahn with the Claude Bernard Medal immediately following his lecture on the final day of the meeting, Sept. 9.

Over the past three decades, the research of Dr. Kahn has literally defined the field of insulin signal transduction and mechanisms of altered signaling in disease. In 1981, Dr. Kahn's laboratory discovered that the insulin receptor is an insulin-stimulated enzyme with protein tyrosine kinase activity. His laboratory also demonstrated how insulin signaling is altered in insulin-resistant states, such as type 2 diabetes and obesity; the impact of genetics and environment on these signaling functions; and how knowledge gleaned from these studies can be translated into new treatment methods for people with diabetes.

In recent studies, Dr. Kahn and his colleagues have conducted a series of studies using genetically engineered mice with knocked out insulin receptors in classical target tissues, such as liver, muscle and fat. These experiments indicated the important link between obesity, diabetes and longevity. Using these techniques, Dr. Kahn and collea
'"/>


10-Sep-2004


Page: 1 2 3

Related biology news :

1. Joslin Diabetes Center honors brothers living 70-plus years with type 1 diabetes
2. Joslin researchers clarify mechanisms for beta-cell formation
3. Joslin Diabetes Center adds first affiliate in California at Irvine Medical Center
4. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
5. Joslin Diabetes Center launches research section on developmental and stem cell biology
6. Joslin Diabetes Center releases new low impact exercise video
7. Joslin researchers identify key molecule in Type 1 diabetes progression
8. As obesity skyrockets, Joslin Diabetes Center urges action to stem the tide of type 2 diabetes
9. AAAS US Presidential Candidates Forum
10. US Presidential Candidates Forum
11. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2018)... ... November 08, 2018 , ... Boekel Scientific ... blocks, also known as dry bath incubators are used in laboratories worldwide for ... , For the new heating blocks, Boekel Scientific used the same interface design ...
(Date:11/7/2018)... ... November 07, 2018 , ... Features such as ... to last-minute changes all contribute to client retention and referral business in the ... and expense services provider says 80 percent of its new business is attributed ...
(Date:11/7/2018)... ... November 07, 2018 , ... ... commercialization, has just released a new white paper discussing Critical-to-Quality (CTQ) Flowup ... its value for managing both critical quality requirements and overall product quality. As ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... ... 08, 2018 , ... IC System, one of the largest ... increasing recovery rates by creating a comprehensive contact strategy for each consumer. ... NLP Logix, a Jacksonville, Florida-based AI solutions company, and leveraged the decades of ...
(Date:11/6/2018)... and TAHOE, Nev. (PRWEB) , ... November 06, ... ... to their native mobile app for clinical trial data collection and management. ... Now, iPhone users with compatible generation devices can quickly and easily sign in ...
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has completed a non-exclusive ... effector code technology for applications in advancing research in epigenetic technology. , ... discovery in 2009, the efficacy of TAL effector-based DNA targeting has been established ...
(Date:10/31/2018)... FREMONT, Calif. (PRWEB) , ... October 30, 2018 ... ... enrollment in its randomized, controlled trial at the Campbell Clinic in Memphis, Tennessee. ... the iovera° system to the standard of care for managing pain after total ...
Breaking Biology Technology:
Cached News: